Current Understanding of How Extracorporeal Membrane Oxygenators Activate Haemostasis and Other Blood Components

Andrew J Doyle, Beverley J Hunt, Andrew J Doyle, Beverley J Hunt

Abstract

Extracorporeal membrane oxygenators are used in critical care for the management of severe respiratory and cardiac failure. Activation of the coagulation system is initiated by the exposure of blood to synthetic surfaces and the shear stresses of the circuit, especially from device pumps. Initial fibrinogen deposition and subsequent activation of coagulation factors and complement allow platelets and leucocytes to adhere to oxygenator surfaces and enhance thrombin generation. These changes and others contribute to higher rates of thrombosis seen in these patients. In addition, bleeding rates are also high. Primary haemostasis is impaired by platelet dysfunction and loss of their key adhesive molecules and shear stress causes an acquired von Willebrand defect. In addition, there is also altered fibrinolysis and lastly, administration of systemic anticoagulation is required to maintain circuit patency. Further research is required to fulyl establish the complexities of the haemostatic changes with these devices, and to elucidate the mechanistic changes that are mainly responsible so that plans can be made to reduce their complications and improve management.

Keywords: ECMO; Haemostasis; cardiopulmonary bypass; hemorrhage; thrombosis; ventricular assist device.

Figures

Figure 1
Figure 1
The prothrombotic changes described by Virchow's triad in respect to (A) the ECMO circuit and (B) patient factors.
Figure 2
Figure 2
Initial interactions between circuit biosurface, haemostatic factors, and components of blood—Tissue Factor (TF), von Willebrand factor (vWF).

References

    1. Kim HS, Cheon DY, Ha SO, Han SJ, Kim HS, Lee SH, et al. . Early changes in coagulation profiles and lactate levels in patients with septic shock undergoing extracorporeal membrane oxygenation. (2018) 10:1418–30. 10.21037/jtd.2018.02.28
    1. Cooper E, Burns J, Retter A, Salt G, Camporota L, Meadows CI, et al. . Prevalence of venous thrombosis following venovenous extracorporeal membrane oxygenation in patients with severe respiratory failure. Crit Care Med. (2015) 43:e581–4. 10.1097/CCM.0000000000001277
    1. Menaker J, Tabatabai A, Rector R, Dolly K, Kufera J, Lee E, et al. . Incidence of cannula-associated deep vein thrombosis after veno-venous extracorporeal membrane oxygenation. ASAIO J. (2017) 63:588–91. 10.1097/MAT.0000000000000539
    1. Paden ML, Conrad SA, Rycus PT, Thiagarajan RR. Extracorporeal life support organization registry report 2012. ASAIO J. (2013) 59:202–10. 10.1097/MAT.0b013e3182904a52
    1. Lubnow M, Philipp A, Foltan M, Bull Enger T, Lunz D, Bein T. No titletechnical complications during venovenous extracorporeal membrane oxygenation and their relevance predicting a system-exchange – retrospective analysis of 265 cases. PLoS ONE (2014) 9:1–22. 10.1371/journal.pone.0112316
    1. Fletcher Sandersjöö A, Bartek J, Thelin EP, Eriksson A, Elmi-Terander A, Broman M, et al. Predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: an observational cohort study. J Intensive Care (2017) 5:27 10.1186/s40560-017-0223-2
    1. Kreyer S, Muders T, Theuerkauf N, Spitzhüttl J, Schellhaas T, Schewe JC, et al. . Hemorrhage under veno-venous extracorporeal membrane oxygenation in acute respiratory distress syndrome patients: a retrospective data analysis. J Thorac Dis. (2017) 9:5017–29. 10.21037/jtd.2017.11.05
    1. Lockie CJA, Gillon SA, Barrett NA, Taylor D, Mazumder A, Paramesh K, et al. . Severe respiratory failure, extracorporeal membrane oxygenation, and intracranial hemorrhage. Crit Care Med. (2017) 45:1642–9. 10.1097/CCM.0000000000002579
    1. Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardio-Thoracic Surg. (2011) 16:342–50. 10.1016/5010-7940(99)00210-9
    1. Young G, Yonekawa KE, Nakagawa P, Nugent DJ. Argatroban as an alternative to heparin in extracorporeal membrane oxygenation circuits. Perfusion (2004) 19:283–8. 10.1191/0267659104pf759oa
    1. Jyoti A, Maheshwari A, Daniel E, Motihar A, Bhathiwal RS, Sharma D. Bivalirudin in venovenous extracorporeal membrane oxygenation. J Extra Corpor Technol. (2014) 46:94–7.
    1. Tay CK, Sung K, Cho YH. ELSO Guidelines for Cardiopulmonary Extracorporeal Life Support. Ann Arbor, MI: Extracorporeal Life Support Organization; (2017). p. 15–7.
    1. Vroman L, Adams AL, Fischer GC, Munoz PC. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood (1980) 55:156–9.
    1. Turbill P, Beugeling T, Poot AA. Proteins involved in the Vroman effect during exposure of human blood plasma to glass and polyethylene. (1996) 17:1279–87. 10.1016/S0142-9612(96)80004-4
    1. Passmore MR, Fung YL, Simonova G, Foley SR, Diab SD, Dunster KR, et al. . Evidence of altered haemostasis in an ovine model of venovenous extracorporeal membrane oxygenation support. Crit Care (2017) 21:1–9. 10.1186/s13054-017-1788-9
    1. Moganasundram S, Hunt BJ, Sykes K, Holton F, Parmar K, Durward A, et al. . The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children. Anesth Analg. (2010) 110:995–1002. 10.1213/ANE.0b013e3181cd6d20
    1. Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care (2016) 20:1–10. 10.1186/s13054-016-1570-4
    1. Poot A, Beugeling T, Cazenave JP, Bantjes A, van Aken WG. Platelet deposition in a capillary perfusion model: quantitative and morphological aspects. Biomaterials (1988) 9:126–32. 10.1016/0142-9612(88)90110-X
    1. Watanabe H, Hayashi J, Ohzeki H. Biocompatibility of a silicone-coated polypropylene hollow fiber oxygenator in an in vitro model. Ann Thorac Surg. (1999) 4975:3–7. 10.1016/S0003-4975(99)00213-1
    1. Bannan S, Danby A, Cowan D, Ashraf S, Gesinde M, Martin P. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model. Eur J Cardiothorac Surg. (1997) 12:268–75. 10.1016/S1010-7940(97)01208-6
    1. Cohen HC, Joyce EJ, Kao WJ. Biomaterials selectively modulate interactions between human blood-derived polymorphonuclear leukocytes and monocytes. Am J Pathol. (2013) 182:2180–90. 10.1016/j.ajpath.2013.02.022
    1. Keuren JF, Wielders SJ, Willems GM, Morra M, Cahalan L, Cahalan P, et al. . Thrombogenicity of polysaccharide-coated surfaces. Biomaterials (2003) 24:1917–24. 10.1016/S0142-9612(02)00620-8
    1. Wahba A, Philipp A, Behr R, Birnbaum DE. Heparin-coated equipment reduces the risk of oxygenator failure. Ann Thorac Surg. (1998) 65:1310–2. 10.1016/S0003-4975(98)00156-8
    1. Malfertheiner MV, Philipp A, Lubnow M, Zeman F, Enger TB, Bein T, et al. . Hemostatic changes during extracorporeal membrane oxygenation: a prospective randomized clinical trial comparing three different extracorporeal membrane oxygenation systems. Crit Care Med. (2016) 44:747–54. 10.1097/CCM.0000000000001482
    1. Hang K, Lau A, Sileika TS, Park SH, Sousa AML, Burch P, et al. Molecular design of antifouling polymer brushes using sequence-specifi c peptoids. Adv Mater Interface (2014) 2014:1400225 10.1002/admi.201400225
    1. de los Santos Pereira A, Sheikh S, Blaszykowski C, Pop-Georgievski O, Fedorov K, Thompson M, et al. . Antifouling polymer brushes displaying antithrombogenic surface properties. Biomacromolecules (2016) 17:1179–185. 10.1021/acs.biomac.6b00019
    1. Obstals F, Vorobii M, Riedel T, de los Santos Pereira A, Bruns M, Singh S, et al. Improving hemocompatibility of membranes for extracorporeal membrane oxygenators by grafting nonthrombogenic polymer brushes. Macromol Biosci. (2018) 2018:1700359 10.1002/mabi.201700359
    1. Kappelmayer J, Bernabei A, Edmunds LH, Edgington TS, Colman RW. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res. (1993) 72:1075–81. 10.1161/01.RES.72.5.1075
    1. Fischer M, Sperling C, Tengvall P, Werner C. The ability of surface characteristics of materials to trigger leukocyte tissue factor expression. Biomaterials (2010) 31:2498–507. 10.1016/j.biomaterials.2009.12.016
    1. Barstad RM, Ovrum E, Ringdal MA, Oystese R, Hamers MJ, Veiby OP, et al. . Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit. Br J Haematol. (1996) 94:517–25. 10.1111/j.1365-2141.1996.tb08989.x
    1. Yau JW, Stafford AR, Liao P, Fredenburgh JC, Roberts R, Weitz JI. Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. Blood (2011) 118:6667–74. 10.1182/blood-2011-07-364141
    1. Tillman B, Gailani D. Inhibition of factors XI and XII for prevention of thrombosis induced by artificial surfaces. Semin Thromb Hemost. (2018) 44:60–9. 10.1055/s-0037-1603937
    1. Boisclair MD, Lane DA, Philippou H, Esnouf MP, Sheikh S, Hunt B, et al. . Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood (1993) 82:3350–7.
    1. Wendel HP, Jones DW, Gallimore MJ. FXII levels, FXIIa-like activities and kallikrein activities in normal subjects and patients undergoing cardiac surgery. Immunopharmacology (1999) 45:141–4.
    1. Plötz FB, van Oeveren W, Bartlett RH, Wildevuur CR. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg. (1993) 105:823–32.
    1. Larsson M, Rayzman V, Nolte MW, Nicke KF, Björkqvist J, Jämsä A, et al. Cardiovascular disease: a factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk. Sci Transl Med. (2014) 6: 222ra17 10.1126/scitranslmed.3006804
    1. May F, Krupka J, Fries M, Thielmann I, Pragst I, Weimer T, et al. . FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis. Br J Haematol. (2016) 173:769–778. 10.1111/bjh.13990
    1. Davidson SJ, Burman JF, Philips SM, Onis SJ, Kelleher AA, De Souza AC, et al. . Correlation between thrombin potential and bleeding after cardiac surgery in adults. Blood Coagul Fibrinolysis. (2003) 14:175–9. 10.1097/00001721-200302000-00009
    1. Kopp R, Mottaghy K, Kirschfink M. Mechanism of complement activation during extracorporeal blood-biomaterial interaction: Effects of heparin coated and uncoated surfaces. ASAIO J. (2002) 48:598–605. 10.1097/00002480-200211000-00005
    1. Vallhonrat H, Swinford RD, Ingelfinger JR, Williams WW, Ryan DP, Tolkoff-Rubin N, et al. Rapid activation of the alternative pathway of complement by ECMO. ASAIO J. (1999) 45:113–4.
    1. Graulich J, Sonntag J, Marcinkowski M, Bauer K, Kössel H, Bührer C, et al. . Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation. Mediators Inflamm. (2002) 11:69–73. 10.1080/09629350220131908
    1. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, et al. . Activation of the complement system during and after cardiopulmonary bypass surgery. Circulation (1997) 96:1–14. 10.1161/01.CIR.96.10.3542
    1. Ivanovich P, Chenoweth DE, Schmidt R, Klinkmann H, Boxer LA, Jacob HS, et al. . Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int. (1983) 24:758–63. 10.1038/ki.1983.224
    1. Westfall SH, Stephens C, Kesler K, Connors RH, Tracy TF, Weber TR. Complement activation during prolonged extracorporeal membrane oxygenation. Surgery (1991) 110:887–91.
    1. Cheung AK, Hohnholt M, Gilson J. Adherence of neutrophils to hemodialysis membranes: Role of complement receptors. Kidney Int. (1991) 40:1123–33. 10.1038/ki.1991.324
    1. Wilm J, Philipp A, Müller T, Bredthauer A, Gleich O, Schmid C, et al. . Leukocyte adhesion as an indicator of oxygenator thrombosis during extracorporeal membrane oxygenation therapy? ASAIO J. (2017) 64:24–30. 10.1097/MAT.0000000000000586
    1. Keragala CB, Draxler DF, McQuilten ZK, Medcalf RL. Haemostasis and innate immunity – a complementary relationship: a review of the intricate relationship between coagulation and complement pathways. Br J Haematol. (2018) 180:782–98. 10.1111/bjh.15062
    1. Delabranche X, Helms J, Meziani F. Immunohaemostasis: a new view on haemostasis during sepsis. Ann Intensive Care (2017) 7:1–14. 10.1186/s13613-017-0339-5
    1. Graulich J, Walzog B, Marcinkowski M, Bauer K, Kössel H, Fuhrmann G, et al. . Leukocyte and endothelial activation in a laboratory model of extracorporeal membrane oxygenation (ECMO). Pediatr Res. (2000) 48:679–84. 10.1203/00006450-200011000-00021
    1. Anderson HL, Coran AG, Drongowski RA, Ha HJ, Bartlett RH. Extracellular fluid and total body water changes in neonates undergoing extracorporal membrane oxygenation. J Pediatr Surg. (1992) 27:1003–8. 10.1016/0022-3468(92)90547-K
    1. Abrams D, Baldwin MR, Champion M, Agerstrand C, Eisenberger A, Bacchetta M, et al. . Thrombocytopenia and extracorporeal membrane oxygenation in adults with acute respiratory failure: a cohort study. Intensive Care Med. (2016) 42:844–52. 10.1007/s00134-016-4312-9
    1. Lukito P, Wong A, Jing J, Arthur JF, Marasco SF, Murphy DA, et al. . Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI. J Thromb Haemost. (2016) 14:2253–60. 10.1111/jth.13497
    1. Cheung PY, Sawicki G, Salas E, Etches PC, Schulz R, Radomski MW. The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med. (2000) 28:2584–90. 10.1097/00003246-200007000-00067
    1. Hase T, Sirajuddin S, Maluso P, Bangalore R, DePalma L, Sarani B. Platelet dysfunction in critically ill patients. Blood Coagul Fibrinolysis (2017) 28:475–8. 10.1097/MBC.0000000000000625
    1. Kalbhenn J, Schlagenhauf A, Rosenfelder S, Schmutz A, Zieger B. Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery. J Hear Lung Transplant. (2018) 37:985–91. 10.1016/j.healun.2018.03.013
    1. Kalbhenn J, Schmidt R, Nakamura L, Schelling J, Rosenfelder S, Zieger B. Early Diagnosis of Acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy. J Atheroscler Thromb. (2015) 22:265–71. 10.5551/jat.27268
    1. Dewanjee MK, Wu SM, Kapadvanjwala M, De D, Dewanjee S, Gonzalez L, et al. . Emboli from an extraluminal blood flow hollow fiber oxygenator with and without an arterial filter during cardiopulmonary bypass in a pig model. ASAIO J. (1996) 42:1010–8. 10.1097/00002480-199642060-00015
    1. Pugsley W, Klinger L, Paschalis C, Aspey B, Newman S, Harrison M, et al. Microemboli and cerebral impairment during cardiac surgery. Vasc Surg. (1990) 24:34–43. 10.1177/153857449002400107
    1. Meyer AD, Gelfond JA, Wiles AA, Freishtat RJ, Rais-Bahrami K. Platelet-derived microparticles generated by neonatal extracorporeal membrane oxygenation systems. ASAIO J. (2015) 16:37–42. 10.1097/MAT.0000000000000164
    1. Miyazaki Y, Nomura S, Miyake T, Kagawa H, Kitada C, Taniguchi H, et al. . High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood (1996) 88:3456–64.
    1. Heilmann C, Geisen U, Beyersdorf F, Nakamura L, Benk C, Trummer G, et al. . Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med. (2012) 38:62–8. 10.1007/s00134-011-2370-6
    1. Pasala S, Fiser RT, Stine KC, Swearingen CJ, Prodhan P. Von willebrand factor multimers in pediatric extracorporeal membrane oxygenation support. ASAIO J. (2014) 60:419–23. 10.1097/MAT.0000000000000084
    1. Tauber H, Ott H, Streif W, Weigel G, Loacker L, Fritz J, et al. . extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von willebrand factor multimers. Anesth Analg. (2015) 120:730–6. 10.1213/ANE.0000000000000554
    1. Adachi I, Kostousov V, Hensch L, Chacon-Portillo MA, Teruya J. Management of hemostasis for pediatric patients on ventricular-assist devices. Semin Thromb Hemost. (2018) 44:30–7. 10.1055/s-0037-1607982
    1. Vincent F, Rauch A, Loobuyck V, Robin E, Nix C, Vincentelli A, et al. . Arterial pulsatility and circulating von willebrand factor in patients on mechanical circulatory support. J Am Coll Cardiol. (2018) 71:2106–118. 10.1016/j.jacc.2018.02.075
    1. Halaweish I, Cole A, Cooley E, Lynch WR, Haft JW. Roller and centrifugal pumps. ASAIO J. (2015) 61:496–501. 10.1097/MAT.0000000000000243
    1. McVeen RV, Lorch V, Carroll RC, Goldberg L, Keszler M, Podlasek S, et al. Letter to the editor: Changes in fibrinolytic factors in newborns during extracorporeal membrane oxygenation (ECMO). Am J Hematol. (1991) 38:254–55.
    1. Hundalani SG, Nguyen KT, Soundar E, Kostousov V, Bomgaars L, Moise A., et al. . Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Pediatr Crit Care Med. (2014) 15: e198–205. 10.1097/PCC.0000000000000107
    1. Hunt BJ, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg. (1998) 65:712–18. 10.1016/S0003-4975(97)01345-3
    1. Sigaut S, Tremey B, Outtara A, Couturier R, Tablerlet C, Grassin-Delyle S., et al. Comparison of two doses of tranexamic acid in adults bypass. Anesthesiology. (2018) 2:590–600. 10.1097/ALN.0b013e3182a443e8
    1. Lou S, MacLaren G, Best D, Delzoppo C, Butt W. Hemolysis in pediatric patients receiving centrifugal-pump extracorporeal membrane oxygenation: Prevalence, risk factors, and outcomes. Crit Care Med. (2014) 42:1213–20. 10.1097/CCM.0000000000000128
    1. Omar HR, Mirsaeidi M, Socias S, Sprenker C, Caldeira C, Camporesi EM, et al. . Plasma free hemoglobin is an independent predictor of mortality among patients on extracorporeal membrane oxygenation support. PLOS ONE (2015) 10:e0124034. 10.1371/journal.pone.0124034
    1. Marcus, Aaron J, Broekman MJ. Cell-free hemoglobin as an oxygen carrier removes nitric oxide, resulting in defective thromboregulation. Circulation (1996) 92:208–9.
    1. Da Q, Teruya M, Guchhait P, Teruya J, Olson JS, Cruz MA. Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: Implications for circulatory devices. Blood (2015) 126:2338–41. 10.1182/blood-2015-05-648030
    1. Van Der Meijden PE, Van Schilfgaarde M, Van Oerle R, Renné T, ten Cate H, Spronk HM. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. (2012) 10:1355–62. 10.1111/j.1538-7836.2012.04758.x

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe